SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing a significant surge in momentum as investors anticipate a potential short squeeze ahead of upcoming earnings, fueled by elevated short interest and heavy trading volume. The community is actively tracking institutional participation and debating whether the stock's recent volatility signals a broader breakout in the voice AI sector.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is trending as the community highlights its recent recognition in a major quantum computing paper, which analysts believe validates its post-quantum security credentials. Enthusiasts are actively debating the long-term potential of the chain's institutional developments while some remain skeptical about its price performance compared to historical highs.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing renewed community activity, with long-term holders debating the project's potential for future growth while some participants express frustration over price stagnation. Sentiment remains highly polarized, oscillating between optimistic calls for a market breakout and ongoing skepticism regarding the token's long-term utility.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is seeing a massive surge in volume and retail interest driven by high-profile endorsements from investors like Bill Ackman and Michael Burry, who are highlighting the stock as significantly undervalued. The community is actively debating the likelihood of a near-term IPO, potential conservatorship exit, and the influence of political rhetoric on the stock's future.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as the community reacts to the company's announcement of an end-of-Phase 2 meeting with the FDA and the established registration path for its lead program, CAD-1005. While some investors are optimistic about the upcoming Phase 3 trial for heparin-induced thrombocytopenia, others remain skeptical due to persistent concerns regarding dilution and the frequent use of bot-driven spam to artificially drive social sentiment.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

Community sentiment regarding the MELANIA token remains overwhelmingly negative, with users characterizing the asset as a pump-and-dump scheme associated with the Trump family. Investors frequently highlight significant losses and criticize the lack of utility, while discussions continue to draw parallels to broader concerns regarding political influence and transparency.

StealthGas, Inc. engages in the provision of international energy seaborne transportation services to liquefied petroleum gas sectors. It owns fleet of vessels that carry petroleum and petrochemical gas products in liquefied form such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer. The company was founded in December 22, 2004 and is headquartered in Athens, Greece.

StealthGas Inc

StealthGas Inc. is trending as investors highlight its debt-free balance sheet, strong cash position, and solid earnings performance in a cyclical LPG shipping market. Community discussions center on the company's attractive valuation relative to its assets, with some market participants monitoring its potential to capitalize on rising charter rates driven by global energy demand.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver (AGQ) is seeing intense volatility as market participants debate whether current geopolitical tensions, industrial demand, and low physical inventories will fuel a sustained short squeeze. Community sentiment is deeply divided, with many traders closely monitoring the relationship between spot silver prices, the U.S. dollar, and potential intervention from global markets like Shanghai.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is trending as investors weigh its aggressive pivot toward AI and high-performance computing infrastructure against concerns regarding capital expenditures, share dilution, and the absence of a long-awaited strategic AI partnership. While some community members remain bullish on the company's efficient mining operations and energy-linked assets, others are actively debating high short interest and management's capital allocation strategy ahead of upcoming earnings.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

MSTZ is trending as investors actively debate the sustainability of MicroStrategy's rally, with a vocal community of traders utilizing the 2X inverse ETF to bet against MSTR's valuation. While some participants are aggressively scaling into short positions to hedge against potential Bitcoin volatility, others are debating whether current price action represents a temporary correction or a deeper structural decline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sandro Wealth Management LLC Invests $1.96 Million in Roivant Sciences Ltd. $ROIV

Sandro Wealth Management LLC purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 90,267 shares of the company's stock, va...

Jennison Associates LLC Invests $51.07 Million in Roivant Sciences Ltd. $ROIV

Jennison Associates LLC bought a new stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange...

Pictet Asset Management Holding SA Raises Holdings in Roivant Sciences Ltd. $ROIV

Pictet Asset Management Holding SA lifted its position in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 790.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,312,436 shares of the company's stock after purchasing...

UBS Group AG Grows Stock Holdings in Roivant Sciences Ltd. $ROIV

UBS Group AG raised its stake in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 570.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,390,792 shares of the company's stock after buying an additional 1...

Roivant Sciences Ltd. $ROIV Stake Cut by Impax Asset Management Group plc

Impax Asset Management Group plc reduced its holdings in Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 69.4% in the 4th quarter, according to the company in its most recent 13F filing with the...

M&T Bank Corp Takes Position in Roivant Sciences Ltd. $ROIV

M&T Bank Corp bought a new stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities...

Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 200,000 Shares

Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Eric Venker sold 200,000 shares of the stock in a transaction dated Monday, April 20th. The stock was sold at an average price of $29.59, for...

Roivant Sciences (NASDAQ:ROIV) CEO Matthew Gline Sells 289,774 Shares

Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) CEO Matthew Gline sold 289,774 shares of the firm's stock in a transaction that occurred on Thursday, April 16th. The shares were sold at an...

Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Rating of "Moderate Buy" by Brokerages

Roivant Sciences Ltd. (NASDAQ:ROIV - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eleven brokerages that are covering the stock, MarketBeat Ratings reports. One...

Elevate Capital Advisors LLC Sells 36,236 Shares of Roivant Sciences Ltd. $ROIV

Elevate Capital Advisors LLC cut its stake in shares of Roivant Sciences Ltd. (NASDAQ:ROIV - Free Report) by 31.8% during the 4th quarter, according to its most recent 13F filing with the Securities...

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.

ROIV
Roivant Sciences Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ROIV News

ROIVRoivant Sciences Ltd